[Effects of progestins on human endometrium in vitro].

Bull Acad Natl Med

Laboratoire d'Anatomie Pathologique, Faculté de Médecine Nord, Bd Pierre Dramard-13916 Marseille.

Published: May 2003

AI Article Synopsis

  • - The study developed an in vitro model to analyze how hormone treatments affect human endometrial cell growth, specifically focusing on therapies used during menopause to help predict and prevent precancerous changes in the endometrium.
  • - Various progestins, including progesterone, MPA, TX, and NOR, were tested for their impact on endometrial tissues, measuring factors like prostaglandin F2 alpha output and the expression of hormone receptors and proliferation markers.
  • - Results indicated that progestin treatments reduced both PGF2 alpha output and hormonal receptor expression, but effects varied based on the type of endometrial tissue, suggesting targeted research is needed to explore endometrial growth dynamics.

Article Abstract

In order to obtain a better evaluation of the epithelial proliferation of the human endometrium, we developed an "in vitro" model to quantify the effects of hormonal treatments, as an "hormonogram". We particularly aimed to evaluate the effects of steroids used in the replacement hormone therapy during menopausis in the view of predicting and preventing the development of precancerous lesions of the endometrium. This study has evaluated the effects of different progestins currently used in hormone therapy, progesterone, medroxy-progesterone acetate (MPA), nomegestrol acetate (TX), norethindrone acetate (NOR) on human proliferative endometrium explant culture, using two means: prostaglandin F2 alpha (PGF2 alpha) output in medium culture, and immunoexpression of estradiol receptor (ER), progesterone receptor (PR) and proliferative antigen Ki67 in tissue. After culture, quantitative studies on ER or PR immunoexpression could be assessed by image analysis procedure in contrast to Ki67 immunoexpression too weak low in non tumorous endometrium to be quantified. PGF2 alpha output, was decreased by progesterone, TX and MPA in both proliferative endometrium subtypes. With regards to receptor immunoexpression, progesterone only decreased PR expression in proliferative endometrium. PR immunoexpression in stromal cells was decreased by all progestins in homogeneous proliferative endometrium explants. TX decreased PR and ER expression in glands and stroma of homogeneous proliferative endometrium. MPA exhibited similar effects but only on heterogeneous proliferative endometrium. In brief, our results show that in vitro progestative treatment on endometrium reduced PGF2 alpha output and decreased PR and/or ER immunoexpression, although the in vitro effects of each progestin were not similar and varied with the endometrium subtype (proliferative homogeneous or heterogeneous). This study opens new fields of research particularly to investigate the endometrial proliferative activity using explant culture.

Download full-text PDF

Source

Publication Analysis

Top Keywords

proliferative endometrium
24
endometrium
12
pgf2 alpha
12
alpha output
12
proliferative
9
human endometrium
8
hormone therapy
8
explant culture
8
output decreased
8
decreased expression
8

Similar Publications

[Solid, endometrial-like and transitional growth patterns of ovarian high-grade serous carcinoma: a clinicopathological analysis of 25 cases].

Zhonghua Bing Li Xue Za Zhi

February 2025

Department of Pathology, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou 215002, China.

To investigate the clinicopathological characteristics of solid, endometrial-like and transitional (SET) cell growth subtype in high-grade serous ovarian carcinoma (HGSC). Clinical data of 25 cases of HGSC-SET were collected from January 2020 to March 2024 at the Affiliated Suzhou Hospital of Nanjing Medical University, and their histological features were analyzed. Immunohistochemical stains were used to analyze the expression of ER, PR, PAX8, WT-1, p16, p53 and Ki-67.

View Article and Find Full Text PDF

Porcine endometrial epithelial organoids: Generation, characterization, and the impact of stromal cells.

Theriogenology

January 2025

Key Laboratory of Animal Cellular and Genetic Engineering of Heilongjiang Province, College of Life Science, Northeast Agricultural University, Harbin, 150030, China. Electronic address:

Endometrial organoids (EOs) are three-dimensional models that emulate the endometrium, serving as an invaluable in vitro tool for investigating the cellular and molecular mechanisms underlying endometrial physiology and pathology during the estrous cycle and pregnancy. While significant progress has been made in the establishment and optimization of EOs for both humans and mice, research on such models in other species remains limited. This study aimed to develop porcine endometrial epithelial organoids (EEOs) to explore the regulatory mechanisms of uterine function and maternal-fetal interactions during porcine pregnancy, which are critical for enhancing reproductive efficiency and improving embryo transfer techniques.

View Article and Find Full Text PDF

Endometriosis is a chronic inflammatory disorder characterized by presence of endometrial tissue outside the uterine cavity. Immunohistochemical analysis (IHC) revealed markedly elevated expression of IL6ST in endometrial tissue of patients with ovarian endometriosis. Level of methylation of IL6ST is diminished in patients with endometriosis, whereas level of mRNA expression is markedly elevated by RT-PCR.

View Article and Find Full Text PDF

The endometrium, the inner lining of the uterus, assumes a crucial role in the female reproductive system. Disorders and injuries impacting the endometrium can lead to profound consequences, including infertility and compromised women's overall health. Recent advancements in stem cell research have opened new possibilities for the treatment and repair of endometrial issues.

View Article and Find Full Text PDF

PCOS Influences the Expression of AMHRII in the Endometrium of AEH During the Reproductive Age.

Diagnostics (Basel)

December 2024

Women's Hospital, School of Medicine, Zhejiang University, Hangzhou 310006, China.

Background: Endometrial proliferative lesions (EPLs) encompass endometrial hyperplasia (EH) and endometrial carcinoma (EC). Atypical endometrial hyperplasia (AEH) is associated with an elevated risk of progression to EC. Patients with polycystic ovarian syndrome (PCOS) exhibit higher serum levels of anti-Müllerian hormone (AMH) and a correspondingly increased incidence of EPLs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!